SS
COGT icon

Sunbelt Securities’s Cogent Biosciences COGT Stock Holding History

Sunbelt Securities’s Portfolio COGT Stock Details COGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.54K Hold
40
– – ﹤0.01% 1991
2025
Q4 		$1.42K Hold
40
– – ﹤0.01% 1967
2025
Q3 		$574 Buy
+40
New +$474 ﹤0.01% 2193

Other funds holding COGT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

Sunbelt Securities's COGT Position: Q1 2026 in Review

Sunbelt Securities held its Cogent Biosciences (COGT) position steady in Q1 2026 at 40 shares worth $1.54K. The position accounts for ﹤0.01% of the portfolio, ranked #1991.

Sunbelt Securities first reported a position in COGT in Q3 2025 and has held it in 3 quarters since. 305 funds tracked by Wall St. Rank hold COGT as of Q1 2026.

  • Sunbelt Securities held 40 shares of Cogent Biosciences worth $1.54K as of Q1 2026.
  • Sunbelt Securities left its Cogent Biosciences share count unchanged in Q1 2026.
  • Cogent Biosciences made up ﹤0.01% of Sunbelt Securities's portfolio in Q1 2026, its #1991 holding.
  • Sunbelt Securities first reported a position in Cogent Biosciences in Q3 2025 and has held it in 3 quarters since.
  • 305 funds tracked by Wall St. Rank held Cogent Biosciences as of Q1 2026.

Based on Sunbelt Securities's 13F filing for Q1 2026, filed 18 May 2026.